year end movements are influenced by tax loss selling and not indicative of company health
When we get into January the selling pressure will disappear, the big boys will be back buying in a big way
as they view this as a great digital play, reason institutions have been net buyers of the stock if you look at the 13F filings last quarter.
the fact that you blocked me comes as no surprise...you obviously have a great level of difficulty when it comes to accepting the facts. but, the fact (which you seem to refer to as bs) as that the stock price of dxm and it's various predecessor companies (rhd/dex & idrc/spmd) have been on a sustained downtrend since late 2006/early 2007. i was being generous when i said 5 years. it's interesting how you want to make it seem as though it is only a recent trend. are you intentionally ignoring the facts, are you completely ignorant, or what?